BENITIONSClinical Trial Intelligence

Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes

該当なし 完了 NCT06127251

対象疾患Obesity
該当なし
スポンサーEmory University
ステータス完了
参加者数54 名
介入(薬剤)PATH Intervention, Control Group, Physical activity tracker, Dietary education
開始日2024年4月11日
完了日2025年5月18日
結果公開日2026年7月22日

概要

The phenomenon of physical activity (PA) avoidance in obesity has been detailed in the literature, but there is a lack of programs designed to address the root causes. In addition to common PA barriers such as lack of time, individuals with obesity face weight-related impediments, including stigma, shame, poor fitness, and low exercise self-efficacy, which reduce their engagement in PA. These impediments have been observed in white and minoritized populations. Numerous studies have suggested that individuals with obesity prefer activities that are enjoyable, less exhausting, and conveniently available in settings where they are not exposed to stigma. The studies also point to a need for programs that focus on the general health benefits of PA rather than weight loss, which although desirable, can be elusive. Unmet weight loss expectations contribute to high dropout rates and non-adherence to the prescribed PA regimen among those with obesity. This is particularly consequential for minoritized populations including African Americans who tend to lose less weight in lifestyle interventions but achieve significant improvements in many cardiometabolic outcomes. In this proposal, investi

Participants Enrolled Within 4 Months of Study Opening

4 months after screening procedures start · Participants

PATH Intervention27 Participants
Control Group27 Participants

Number of Participants Retained in Each Group

12 weeks · Participants

PATH Intervention26 Participants
Control Group27 Participants

The System Usability Scale

12 weeks · score on a scale

PATH Intervention79.6 ± 13.3 score on a scale

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。